Pratley RE - Search Results

1

Beta-cell function in mild type 2 diabetic patients: effects of 6-month glucose lowering with nateglinide.

Mari A, Gastaldelli A, Foley JE, Pratley RE, Ferrannini E. Mari A, et al. Among authors: pratley re. Diabetes Care. 2005 May;28(5):1132-8. doi: 10.2337/diacare.28.5.1132. Diabetes Care. 2005. PMID: 15855578 Clinical Trial.

2

Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance.

Weyer C, Bogardus C, Pratley RE. Weyer C, et al. Among authors: pratley re. Diabetes. 1999 Nov;48(11):2197-203. doi: 10.2337/diabetes.48.11.2197. Diabetes. 1999. PMID: 10535454

3

Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance.

Weyer C, Foley JE, Bogardus C, Tataranni PA, Pratley RE. Weyer C, et al. Among authors: pratley re. Diabetologia. 2000 Dec;43(12):1498-506. doi: 10.1007/s001250051560. Diabetologia. 2000. PMID: 11151758

4

Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development.

Weyer C, Tataranni PA, Bogardus C, Pratley RE. Weyer C, et al. Among authors: pratley re. Diabetes Care. 2001 Jan;24(1):89-94. doi: 10.2337/diacare.24.1.89. Diabetes Care. 2001. PMID: 11194248

5

Subcutaneous abdominal adipocyte size, a predictor of type 2 diabetes, is linked to chromosome 1q21--q23 and is associated with a common polymorphism in LMNA in Pima Indians.

Weyer C, Wolford JK, Hanson RL, Foley JE, Tataranni PA, Bogardus C, Pratley RE. Weyer C, et al. Among authors: pratley re. Mol Genet Metab. 2001 Mar;72(3):231-8. doi: 10.1006/mgme.2001.3147. Mol Genet Metab. 2001. PMID: 11243729

6

Rapid acting insulinotropic agents: restoration of early insulin secretion as a physiologic approach to improve glucose control.

Pratley RE, Foley JE, Dunning BE. Pratley RE, et al. Curr Pharm Des. 2001 Sep;7(14):1375-97. doi: 10.2174/1381612013397348. Curr Pharm Des. 2001. PMID: 11472274 Review.

7

Management of type 2 diabetes in treatment-naive elderly patients: benefits and risks of vildagliptin monotherapy.

Pratley RE, Rosenstock J, Pi-Sunyer FX, Banerji MA, Schweizer A, Couturier A, Dejager S. Pratley RE, et al. Diabetes Care. 2007 Dec;30(12):3017-22. doi: 10.2337/dc07-1188. Epub 2007 Sep 18. Diabetes Care. 2007. PMID: 17878242 Clinical Trial.

8

Robust improvements in fasting and prandial measures of beta-cell function with vildagliptin in drug-naïve patients: analysis of pooled vildagliptin monotherapy database.

Pratley RE, Schweizer A, Rosenstock J, Foley JE, Banerji MA, Pi-Sunyer FX, Mills D, Dejager S. Pratley RE, et al. Diabetes Obes Metab. 2008 Sep;10(10):931-8. doi: 10.1111/j.1463-1326.2007.00835.x. Epub 2007 Dec 17. Diabetes Obes Metab. 2008. PMID: 18093207

9

Effect of ovarian suppression with gonadotropin-releasing hormone agonist on glucose disposal and insulin secretion.

Toth MJ, Cooper BC, Pratley RE, Mari A, Matthews DE, Casson PR. Toth MJ, et al. Among authors: pratley re. Am J Physiol Endocrinol Metab. 2008 Jun;294(6):E1035-45. doi: 10.1152/ajpendo.00789.2007. Epub 2008 Apr 15. Am J Physiol Endocrinol Metab. 2008. PMID: 18413671 Free PMC article. Clinical Trial.

10

Clinical measures of islet function: usefulness to characterize defects in diabetes.

Ahrén B, Pratley RE, Soubt M, Dunning BE, Foley JE. Ahrén B, et al. Among authors: pratley re. Curr Diabetes Rev. 2008 May;4(2):129-45. doi: 10.2174/157339908784220714. Curr Diabetes Rev. 2008. PMID: 18473760 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

435 results

Search Page

Filters